19-10113961-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_002566.5(P2RY11):​c.348C>T​(p.Ser116Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0039 in 1,601,950 control chromosomes in the GnomAD database, including 190 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0030 ( 13 hom., cov: 34)
Exomes 𝑓: 0.0040 ( 177 hom. )

Consequence

P2RY11
NM_002566.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.04

Publications

2 publications found
Variant links:
Genes affected
P2RY11 (HGNC:8540): (purinergic receptor P2Y11) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is coupled to the stimulation of the phosphoinositide and adenylyl cyclase pathways and behaves as a selective purinoceptor. Naturally occuring read-through transcripts, resulting from intergenic splicing between this gene and an immediately upstream gene (PPAN, encoding peter pan homolog), have been found. The PPAN-P2RY11 read-through mRNA is ubiquitously expressed and encodes a fusion protein that shares identity with each individual gene product. [provided by RefSeq, Jul 2008]
PPAN-P2RY11 (HGNC:33526): (PPAN-P2RY11 readthrough) This locus represents naturally occurring read-through transcription between the adjacent PPAN and P2RY11 genes. Alternative splicing results in two transcript variants, one of which encodes a fusion protein that shares sequence identity with each individual gene product. This transcript is found to be ubiquitously expressed and is up-regulated by agents inducing granulocytic differentiation. However, its functional significance in vivo remains unclear. [provided by RefSeq, Nov 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 19-10113961-C-T is Benign according to our data. Variant chr19-10113961-C-T is described in ClinVar as Benign. ClinVar VariationId is 779032.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.04 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00301 (459/152332) while in subpopulation SAS AF = 0.0519 (251/4832). AF 95% confidence interval is 0.0467. There are 13 homozygotes in GnomAd4. There are 279 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002566.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
P2RY11
NM_002566.5
MANE Select
c.348C>Tp.Ser116Ser
synonymous
Exon 2 of 2NP_002557.2
PPAN-P2RY11
NM_001040664.3
c.1608C>Tp.Ser536Ser
synonymous
Exon 13 of 13NP_001035754.1A0A0B4J1V8
PPAN-P2RY11
NM_001198690.2
c.*107C>T
3_prime_UTR
Exon 13 of 13NP_001185619.1A0A0A6YYI3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
P2RY11
ENST00000321826.5
TSL:1 MANE Select
c.348C>Tp.Ser116Ser
synonymous
Exon 2 of 2ENSP00000323872.4Q96G91
PPAN-P2RY11
ENST00000393796.4
TSL:1
c.1608C>Tp.Ser536Ser
synonymous
Exon 13 of 13ENSP00000377385.4A0A0B4J1V8
PPAN-P2RY11
ENST00000428358.5
TSL:2
c.*107C>T
3_prime_UTR
Exon 13 of 13ENSP00000411918.1

Frequencies

GnomAD3 genomes
AF:
0.00303
AC:
461
AN:
152214
Hom.:
13
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0252
Gnomad SAS
AF:
0.0523
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00826
AC:
1982
AN:
239960
AF XY:
0.0101
show subpopulations
Gnomad AFR exome
AF:
0.000683
Gnomad AMR exome
AF:
0.000782
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0244
Gnomad FIN exome
AF:
0.0000750
Gnomad NFE exome
AF:
0.000279
Gnomad OTH exome
AF:
0.00545
GnomAD4 exome
AF:
0.00399
AC:
5785
AN:
1449618
Hom.:
177
Cov.:
35
AF XY:
0.00518
AC XY:
3735
AN XY:
721674
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33470
American (AMR)
AF:
0.000604
AC:
27
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.0309
AC:
1225
AN:
39690
South Asian (SAS)
AF:
0.0455
AC:
3921
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41460
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5766
European-Non Finnish (NFE)
AF:
0.000145
AC:
161
AN:
1111830
Other (OTH)
AF:
0.00720
AC:
434
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
408
816
1223
1631
2039
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00301
AC:
459
AN:
152332
Hom.:
13
Cov.:
34
AF XY:
0.00375
AC XY:
279
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41558
American (AMR)
AF:
0.00274
AC:
42
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0253
AC:
131
AN:
5180
South Asian (SAS)
AF:
0.0519
AC:
251
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68028
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000567
Hom.:
0
Bravo
AF:
0.00167
Asia WGS
AF:
0.0460
AC:
160
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.33
CADD
Benign
6.8
DANN
Benign
0.95
PhyloP100
1.0
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79800334; hg19: chr19-10224637; API